Ajanta Pharma’s Guwahati facility to be commercialised before March 2017

10 Oct 2016 Evaluate

Drug maker Ajanta Pharma’s new formulations facility set up at Guwahati with a capex of over Rs 300 crore is likely to be commercialised before March 2017. This will enable the company to build its strength in manufacturing and get more tax efficient. The facility will produce tablets, capsules, creams/ointments and sterile ophthalmic liquids.

Moreover, the company’s Dahej manufacturing facility, mainly dedicated for developed markets, will be operational in next financial year.

Ajanta Pharma is a specialty pharmaceutical formulation company with global headquarters in Mumbai, India. The company is engaged in developing, manufacturing and marketing of quality finished dosages across 30+ countries.

 

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×